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a  b  s  t  r  a  c  t
Purpose:  To  report  a case  of Acanthamoeba  keratitis  diagnosed  using  confocal  microscopy  in  a patient
corrected  by  orthokeratology  and  treated  with  corneal  crosslinking  (CXL)  after failure  to  respond  to
medical  treatment.
Methods: After  diagnosis,  the  patient  was  treated  with  several  medications  until  CXL  was applied  during
one  30-min  session  using  ultraviolet  A  radiation  and  application  of  riboﬂavin.  The  clinical  signs  of the
disease  observed  using  slit-lamp  biomicroscopy  and  confocal  microscopy  were  evaluated  and  the  visual
acuity was measured  during  the  course  of the  infection  and  treatment  over  a period  of 30  months  includ-
ing 12 months  of  medical  treatment,  9 months  after  cross-linking  and  amniotic  membrane  transplant
and  9 months  after  penetrating  keratoplasty  and  cataract  extraction.
Results:  In this  case,  confocal  microscopy  facilitated  early  diagnosis  of  an Acanthamoeba  infection  even
if  other  signs  and  symptoms  might  be  confounding.  CXL  was  more  effective  than  aggressive  medication
against  the  microorganism.  After  CXL, the  symptoms  and  the  corneal  appearance  improved  signiﬁcantly
but  the ulcer  did  not  heal  completely.  After  amniotic  membrane  transplantation,  the patient  underwent
penetrating  keratoplasty  (PK)  with  no  rejection,  and  the  visual  function  substantially  improved  over  9
months  of  follow-up.
Conclusions:  Swimming  in contaminated  water  might  represent  a risk  for orthokeratology  patients.  CXL
was  effective  for treating  Acanthamoeba  keratitis  in an  orthokeratology  patient  to eliminate  active and
cystic  forms  of  the microorganism.  Confocal  microscopy  was  useful  to  conﬁrm  the  diagnosis  in the  pres-
ence  of  confounding  clinical  signs  observed  during  a conventional  slit-lamp  examination.  Both CXL  and
confocal  microscopy  are  essential  to  the  outcome  of  PK.
© 2013  British  Contact  Lens  Association.  Published  by Elsevier  Ltd.  All  rights  reserved.
1. Introduction
Acanthamoeba species (spp.), is a unicellular protozoa capable
of forming amoeba cysts, are present in air, soil, and fresh water
(baths, swimming pools, and stagnant water). In humans they are
among the normal oral ﬂora. They are resistant to many disinfect-
ing agents, changes in temperature, and dry environments. The ﬁrst
case of an Acanthamoeba ocular infection was reported in 1974 [1].
Since then many cases have been reported, most of which were
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unilateral. Binocular cases also have been described. In non-contact
lens wearers, infection traditionally has been associated with pre-
vious trauma and subsequent exposure to contaminated water or
soil [2]. This infection is also commonly associated with contact
lens wear, particularly disposable soft contact lenses [3,4]. Acan-
thamoeba has demonstrated to adhere to rigid, rigid gas permeable
and soft contact lenses and it has been hypothesized as a potential
risk for infection [5,6]. In the literature we can ﬁnd Acanthamoeba
infection associated also to rigid gas permeable lenses for orthok-
eratology [7] and also to hybrid lenses [8]. Acanthamoeba infection
related with contact lens wear use to be associated with poor
compliance or contact with contaminated water sources [9,10].
Acanthamoeba has been associated to one of the more recent
contact lens related infections outbreaks in the USA [11], and con-
tinuous efforts are being done by care solutions manufacturers to
increase the efﬁcacy against this resistant microorganism [12–14].
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The pathophysiology of Acanthamoeba infection includes severe
corneal necrosis; establishing the diagnosis is usually difﬁcult and
results in delayed administration of appropriate treatment. The
outcomes can range from partial loss of corneal transparency to
corneal transplant or even enucleation. The differential diagnosis
includes herpes simplex, fungal keratitis, or torpid evolution kerati-
tis [15]. Early treatment is essential for appropriate management,
and confocal microscopy is a powerful tool in this regard [15].
In 2003, Wollensak et al. [16] introduced corneal cross-linking
(CXL), which consists of application of ultraviolet-A (UVA) radia-
tion onto the cornea after epithelial debridement and irrigation
with isomolar riboﬂavin solution at 0.1% at regular intervals to
cross-link the corneal stroma and strengthen the corneal tissue.
CXL is effective for stabilizing keratoconus and post-refractive
surgery ecstatia [17]. In vitro studies also have shown the bac-
tericidal effect of UV radiation, which seems to be enhanced
with riboﬂavin. The treatment is effective against Staphylococcus
aureus, methicillin-resistant S. aureus,  Staphylococcus epider-
midis, Pseudomonas aeruginosa,  multiresistant P. aeruginosa, and
drug-resistant Streptococcus pneumonia [18]. More recently, the
combined application of amphotericin B and riboﬂavin with UV
radiation was effective against Candida albicans, Fusarium spp., and
Aspergillus fumigatus [19].
2. Case report
A 34-year-old woman, who had been wearing corneal refrac-
tive therapy lenses for myopia correction for 3 years, presented
with the complaints of tearing, burning, photophobia, and mod-
erate pain of 4 days duration after having bathed in a swimming
pool that was poorly maintained. The patient worn the current
lenses for 9 months at the time of the event and was compliant
with the care regime consisting of a multipurpose care solution for
gas permeable lenses (Boston Simplus, Bausch & Lomb), a monthly
protein removal (Progent, Menicon) and preservative free artiﬁcial
tears to apply with lens insertion and immediately after wak-
ing every morning (Aquify, Ciba Vision). When she was informed
that she might have an ocular infection, the patient spontaneously
reported that other users of the swimming pool she used to attend
had recently developed ocular infections and other adverse events
potentially related to the quality of the pool water.
Fig. 1. Ulcer formation and follow-up after CXL treatment. Top left, the ulcer after
CXL treatment; top right, the ulcer after CXL stained with sodium ﬂuorescein; bot-
tom left, progression of the ulcer after CXL covered with a therapeutic contact lens;
bottom right, after an amniotic transplantation procedure. Images obtained at 10×
(top  right) and 12× magniﬁcation.
Slit-lamp examination conﬁrmed a mild inferior superﬁcial ker-
atitis. Considering the suspicion of an inﬂammatory adverse event,
a topical antibiotic (Tobrex, Tobramycin, Alcon, Spain) (1 drop, 4
times/day) was  prescribed, and cessation of contact lens wear was
recommended until resolution of the infection. After 5 days of treat-
ment, the pain and photophobia increased, and an examination
revealed inﬁltration with a dendritic ﬂuorescein pattern compati-
ble with a herpetic infection. Acyclovir ointment (GlaxoSmithKline,
Spain) ﬁve times daily was  prescribed. The lack of improvement
within the next 72 h and increasing pain led us to consider the possi-
bility of Acanthamoeba keratitis. Suspect of polymicrobial infection
was considered and epithelial specimens were collected for culture
assays of bacteria, fungi, and Acanthamoeba.  The solution in the con-
tact lens case also was  analyzed. The diagnosis of Acanthamoeba was
conﬁrmed by confocal microscopy (Fig. 1) based on the presence
of subepithelial cysts [20,21]. All other laboratory cultures were
negative.
Treatment consisting of topical chlorhexidine (0.02%),
polymyxin, neomycin, gramicidin (Ophthalmowell, Farmasierra
Manufacturing SL, Madrid, Spain), and propamidine isethion-
ate 0.1% (Brolene, Sanoﬁ Aventis, Surrey, UK); the medications
were instilled hourly during the day and every 4 h at night.
Cyclopentolate 0.1% (Colircusi Cicloplejico, Alcon, Barcelona,
Spain) was  prescribed every 8 h and systemic ketoconazole
(Panfungol, Laboratorios Dr. Esteve SA, Barcelona) 100 mg every
12 h.
After a few weeks of treatment, perineuritis was present, and
the typical ring-shaped inﬁltrate characteristic of Acanthamoeba
keratitis was  observed at a later stage.
After 4 months of intensive treatment with no substan-
tial improvement, propamidine isethionate 0.1% was replaced
with hexamidine 0.1% (Desomedine, Pharma Intenracional, Spain),
and chlorhexidine 0.02% was  replaced with polyhexamethylene
biguanide (PHMB) from Moorﬁelds Eye Hospital, London, UK.
After 1 year, the corneal conditions worsened with ulceration
and recurrent uveitis, and CXL was  performed. Topical anesthe-
sia of the cornea was obtained using oxybuprocaine and tetracaine
drops, alternating every 3 min  for 9 min. During this time period,
pilocarpine 2% eye drops were also instilled twice. After a lid specu-
lum was inserted, a 9.0-mm diameter corneal abrasion was  created.
Riboﬂ avin 0.1% drops were instilled every 3 min for 30 min. The
riboﬂ avin drops were prepared immediately before treatment by
mixing aqueous riboﬂ avin 0.5% solution with dextran T-500 20%
solution. UVA radiation was applied at a rate of 3 mW/cm2 with a
CMB  XLINKER (Ophthaltec, Barcelona, Spain), and riboﬂavin solu-
tion was  applied every 5 min  for 30 min. During irradiation, the
cornea was moistened every 5 min  with riboﬂ avin 0.1% drops and
oxybuprocaine drops every 10 min.
After CXL, the corneal appearance improved signiﬁcantly and
the symptoms resolved. The signs of inﬂammation also resolved
almost immediately, although Acanthamoeba treatment was inter-
rupted only 3 months later. Confocal microscopy at this stage
showed no cysts in the area of analysis.
Six months after CXL, amniotic membrane implantation was
performed to resolve the deﬁcient corneal re-epithelization. Fig. 2
shows the ocular condition at different time points after CXL.
After this stage, corneal melting developed about 8 months
after CXL and 20 months after ﬁrst onset of the infection with
resultant glaucoma and a triple procedure that included glau-
coma and cataract surgeries and penetrating keratoplasty (PK) was
scheduled. The surgeries were performed when no Acanthamoeba
cysts were seen on confocal microscopy. The triple procedure was
uneventful and the patient has had no signs of rejection of the
implant or other complications. Fig. 3 shows the current appear-
ance of the eye with recovery of the best-corrected visual acuity to
20/60.
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Fig. 2. Confocal micrographs of the corneal epithelium (left side), anterior, medium and posterior stroma, and endothelium (right side) in the superior cornea (top row),
central  cornea (medium row) and inferior cornea (bottom row). Bright circular bodies in the epithelial region indicate the presence of Acanthamoeba cysts. The stromal
micrographs depict a highly disorganized structure in the anterior stroma affected by the infection and a progressively less hyper reﬂective aspect at deeper locations.
Hexagonal cell pattern is observed in the endothelial layer, particularly in the superior and central location.
3. Discussion
Fortunately, Acanthamoeba keratitis is rare, but clinicians must
consider it in the differential diagnosis, particularly in patients
who wear contact lenses and present with pain that is incom-
patible with inﬂammation and/or an epithelial defect. Suspects
of non-compliance with care regimes, use of tap water to rinse
contact lenses or exposure to potentially contaminated sources of
water are relevant to suspect the presence the infection. Swim-
ming in lenses is considered a risk factor for Acanthamoeba eye
infection [22]. Orthokeratology represents a different situation
in which the lenses are not work during the water exposure as
the lenses are worn overnight. New techniques allow now an
earlier identiﬁcation of Acanthamoeba infection [23–25], but diag-
nosis is still difﬁcult and most cases of Acanthamoeba keratitis
are misdiagnosed initially as herpetic keratitis and less frequently
as bacterial or fungal keratitis because the symptoms and some-
times the signs are non-speciﬁc [26]. Care should be taken with
negative cultures for bacteria and fungi that do not improve with
medical treatment. Confocal microscopy was useful to conﬁrm the
diagnosis considering that the Acanthamoeba culture is negative
in most cases [20,24]. Early diagnosis and appropriate treatment
are essential for a good outcome in these infections and physi-
cians need to be aware of history of contact lens wear or other
suspicious signs as dendritic keratitis [15]. In this case, despite
Fig. 3. Final outcome after penetrating keratoplasty with a best spectacle corrected
visual acuity of 20/60. Diffuse observation at 12× magniﬁcation.
the relatively early treatment (15 days after the ﬁrst visit and
about 20 days after the initial symptoms), the ﬁnal outcome was
unsatisfactory. Treatment included the drugs of choice for these
cases (diamine and biguanide-derived drugs) neomycin to avoid
induction of bacterial infection, and a cycloplegic agent to relieve
pain due to iris spasms and prevent synechiae. Oral antifungal
drugs 200 mg  every 12 h also have been effective against amoeba
[27].
Considering the possibility of the presence of propamidine-
resistant Acanthamoeba strains, a change in medication also was
considered in this case. PHMB has been effective against the cystic
form of Acanthamoeba even at low concentrations [28,29]. Despite
these considerations, the different medical strategies failed, so a
conservative surgical solution was  considered rather than a pen-
etrating corneal transplant. In addition, penetrating keratoplasty
was not possible while the infection was  active. Additional suspects
of polymicrobial infection were also considered at this point.
The use of UV light as an antimicrobial agent has been long rec-
ognized. However, recently the beneﬁt of the combined application
of UV light and riboﬂavin-A in CXL was found to be more effective
than UV light alone against different strains of bacteria such as S.
epidermidis, S. aureus,  and P. aeruginosa [30]. The current report is
not the ﬁrst on the use of CXL against the collagenolytic activity
of microorganisms such as Acanthamoeba.  Moren et al. performed
CXL to treat a case of presumed Acanthamoeba infection in a con-
tact lens wearer with good wound healing and visual rehabilitation
[31]. Conversely, Rama et al. were unsuccessful when performing
CXL in a patient with keratoconus who developed corneal melting
with a positive culture for Acanthamoeba [32]; corneal perforation
developed 5 days after treatment. The effectiveness of CXL also may
be limited by the depth of the treatment, which usually is limited
to the anterior 300 m.  If the microorganisms penetrate below this
level, the treatment might be unsuccessful. Other cases have been
also recently described in the literature although none was related
with orthokeratology lenses.
To the best of our knowledge, the current study is the ﬁrst to
report the use of CXL to treat an infection caused by corneal refrac-
tive therapy. The safety of orthokeratology has been questioned
after several cases of microbial keratitis developed in children
[7,33], and a review of the potential risks was published recently
by the American Academy of Ophthalmology [34]. Nevertheless,
most cases of infection reported until now presumably were asso-
ciated with potentially risky practices such as poor contact lens
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care systems. The current patient reported swimming daily and
that, at the time of diagnosis, other swimmers in the same pool
had developed ocular infections. The use of lenses in this environ-
ment has been recognized as a potential risk for ocular infection
[22,35]. Despite orthokeratology lenses are not worn while swim-
ming, Acanthamoeba keratitis should not be ruled out in these
patients as the organisms might also be present on the eye when
the lenses are wearing, and this might increase the risk of corneal
attachment and infection as these lenses have been relates with
higher retention of other bacteria as P. aeruginosa [36]. Some stud-
ies have reported similar or higher adhesion of Acanthamoeba to
gas permeable and soft contact lens materials [5,6]. Due to the close
relationship between the cornea and orthokeratology lenses, this
might be a potential risk [36]. Early diagnosis and aggressive treat-
ment are the approaches in such cases. However, when the patient
does not respond to treatment, other alternatives such as CXL might
be considered. Confocal microscopy has been useful for diagnosis
and for ensuring that the cornea is free of residual infection in the
form of trophozoites or cysts before proceeding with penetrating
keratoplasty.
In summary, the use of confocal microscopy was essential in
the current case to establish the diagnosis and initiate an early spe-
ciﬁc treatment. The use of CXL, although it seems to be effective
in stopping the progress of the infection, cannot always result in
a successful deﬁnitive treatment. Furthermore, patients corrected
with orthokeratology should be warned that under certain adverse
conditions a contaminated swimming pool may  pose a potential
risk of severe adverse events.
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